Xencor Inc. (XNCR)
NASDAQ: XNCR
· Real-Time Price · USD
7.58
-0.07 (-0.92%)
At close: Aug 15, 2025, 10:20 AM
-0.92% (1D)
| Bid | 7.55 |
| Market Cap | 540.63M |
| Revenue (ttm) | 164.15M |
| Net Income (ttm) | -177.87M |
| EPS (ttm) | -2.36 |
| PE Ratio (ttm) | -3.21 |
| Forward PE | -2.74 |
| Analyst | Buy |
| Ask | 7.61 |
| Volume | 99,085 |
| Avg. Volume (20D) | 856,004.3 |
| Open | 7.70 |
| Previous Close | 7.65 |
| Day's Range | 7.58 - 7.78 |
| 52-Week Range | 6.92 - 27.24 |
| Beta | 0.89 |
About XNCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XNCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XNCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Xencor has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Xencor Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-21.08%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
11 months ago
+10.45%
Xencor shares are trading higher. The company priced its $175 million offering of 6.635 million shares of its common stock at $18.00 per share.
